AbbVie and Galderma Control 80% of Aesthetic Medicine's AI Citations, New 5W Index Finds
Rhea-AI Summary
5W AI Communications released the Med Spa & Aesthetic Medicine AI Visibility Index 2026, measuring how major AI answer engines route aesthetic medicine patients to brands and providers.
The study finds AbbVie/Allergan and Galderma control 80% of drug and device AI citation share, while Hydrafacial (NASDAQ: SKIN) and other device makers do not appear in the top 25.
Positive
- None.
Negative
- Hydrafacial (NASDAQ: SKIN) does not rank among the top 25 AI-cited aesthetic medicine brands
News Market Reaction – SKIN
In the Jun 23 session, SKIN declined 0.76%, reflecting a mild negative market reaction. Argus tracked a peak move of +4.5% during that session. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 02 | Product launch | Positive | -5.3% | Launch of HydraScalp with Keravive scalp treatment using Vortex-Fusion tech. |
| May 07 | Earnings results | Negative | -36.3% | Q1 2026 results with net sales decline and lowered full-year sales guidance. |
| Apr 29 | Earnings date | Neutral | -3.8% | Announcement of timing for Q1 2026 earnings release and conference call. |
| Apr 22 | Board changes | Positive | -8.2% | Appointment of three independent directors with medtech and aesthetics expertise. |
| Apr 22 | Corporate rebrand | Positive | +2.2% | Rebranding to SkinHealth Systems and emphasis on medical aesthetics platform. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has often coincided with downside moves, including on generally constructive corporate and product updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Top 25 Brands Capture
Its central finding: two pharmaceutical companies — AbbVie/Allergan and Galderma — control
The Index covers a roughly
"Citation share is the new market share. In aesthetic medicine, it is also the new patient pipeline," said Ronn Torossian, founder and chairman of 5W AI Communications. "The brands that don't appear in AI answers are excluded from consideration before the patient ever calls a clinic."
Key Findings
- Botox scored 95 out of 100 — the highest single-brand score in the Index. The drug, the brand, and the category are the same word in nearly every AI answer about wrinkles.
- RealSelf, a patient-review marketplace, scored 86 — higher than every individual med spa, dermatology group, and device brand in the country. The marketplace owns the answer to "is this safe," "what's it like," "how much does it cost," and "how do I find a provider."
- Daxxify, launched by Revance in 2023, already ranks #9 — ahead of Merz's Xeomin, which has been on the market for over a decade.
- LaserAway, the largest national med spa chain at 190+ locations and
$200M + in revenue, ranks #7. Cited less than the smaller marketing budgets of RealSelf and AEDIT combined. - Board-certified dermatology groups — Schweiger,
U.S . Dermatology Partners, and Forefront Dermatology — outrank 19 of the 25 ranked brands. Authority signal beats scale in medical and aesthetic categories. - Device manufacturers including InMode, Cutera, Lutronic, BTL Industries, Solta Medical, and Hydrafacial (NASDAQ: SKIN) failed to crack the top 25. Patients ask AI for outcomes, not machines.
The Visibility Gap
The Index also documents what 5W calls the "Visibility Gap": the top 25 ranked brands capture roughly
"AI did not create the compression we're measuring," Torossian said. "It exposed it. Two pharmaceutical companies effectively control the answer set. Every med spa in America books patients using one of four companies' molecules. The brand wars play out one tier above the clinic."
Methodology
5W ran a standardized prompt set of 65 patient-intent queries across ChatGPT (OpenAI), Claude (Anthropic), Perplexity, Gemini (Google DeepMind), and Google AI Overviews. The prompt set spans toxins, fillers, body contouring, hair removal, skin treatments, location search, safety, cost, and provider selection. Composite scores weight citation frequency
Availability
The Med Spa & Aesthetic Medicine AI Visibility Index 2026 is published in full at 5wpr.com. 5W offers AI Citation Audits delivered in 10 business days and builds custom AI Visibility Indexes on request for aesthetic brands, med spa chains, device manufacturers, and dermatology groups. The full 5W AI Visibility Index series is available online. For licensing, custom Index commissions, or media inquiries, contact info@5wpr.com.
About 5W
5W is the AI Communications Firm, building brand authority across the platforms where decisions now happen — ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews — alongside earned media, digital, and influencer channels. 5W combines public relations, digital marketing, Generative Engine Optimization (GEO), and proprietary AI visibility research to help clients measure and grow their presence in AI-driven buyer research. Founded in 2003, 5W is recognized as a Top U.S. PR Agency by O'Dwyer's, named Agency of the Year in the American Business Awards®, honored as a 2026 Top Place to Work in Communications by Ragan, and named to Digiday's WorkLife Employer of the Year list. 5W serves clients across B2C sectors — Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, and Nonprofit — and B2B specialties including Corporate Communications, Reputation Management, Public Affairs, Crisis Communications, and Digital Marketing across Social, Influencer, Paid Media, GEO, and SEO. Learn more at 5wpr.com.
Media Contact
5W AI Communications
info@5wpr.com
www.5wpr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-and-galderma-control-80-of-aesthetic-medicines-ai-citations-new-5w-index-finds-302808026.html
SOURCE 5W Public Relations